CSCN Gloor Lecture | Daniel Friedman - Cannabinoids for the Treatment of Neurological Disorders

Daniel Friedman, MD, MSc is a Professor (Clinical) of Neurology at NYU Grossman School of Medicine and a member of the Comprehensive Epilepsy Center. He is also the co-director of the Video-EEG laboratory at NYU Langone Medical Center. He received his medical degree from Case Western Reserve University School of Medicine, completed his neurology residency training at the Hospital of the University of Pennsylvania and his epilepsy/clinical neurophysiology fellowship at the Neurological Institute/Columbia University Medical Center. He specializes in the treatment of teenagers and adults with difficult to control epilepsy. He also performs research to better understand the causes of morbidity and mortality of epilepsy and test interventions to improve outcomes. He also serves on the executive committees of the North American SUDEP Registry and the Epilepsy Study Consortium and on the the professional advisory board of the Epilepsy Foundation of America and the EF/SUDEP Institute.

This Lecture will be delivered to our broad audience for an introduction and update on the use of Cannabinoids (CBD) in neurological disorders. Dr Daniel Friedman is an Epileptologist working at NYU with a vast experience in CBD clinical and research applications, largely published in the topic. It will be a great opportunity to learn about the upcoming therapeutic tools available in chronic neurological disorders including epilepsy, neuropathic pain, and spasticity in MS or CP among others.